FOXD2 and breast cancer: In parallel, tissue data from gene expression analysis in BC tissue specimens (TCGA)23 confirms ANKRD36C, FOXD2, collagen alpha-1 chains I, III, IV, VI, XIV, collagen alpha-3 chain IV and collagen alpha-4 chain IV as unfavorable and nebulin as favorable prognostic markers for BC outcome.